How much ergothioneine is in Hokkaido Lion's Mane?

Hokkaido Lion's Mane has been measured to contain 250–583 mg of ergothioneine per 100g dry weight, making it among the higher-ergothioneine mushroom cultivars documented in extraction research. The wide range reflects differences in cultivation conditions, substrate composition, and drying methods used across studies.

Is Hokkaido Lion's Mane different from regular Lion's Mane?

Hokkaido Lion's Mane is a specific cultivar of Hericium erinaceus selected or grown in Hokkaido, Japan, and is distinguished primarily by its elevated ergothioneine content compared to standard commercial strains. While all Hericium erinaceus strains may produce hericenones and erinacines, the Hokkaido cultivar's published research focuses on polysaccharide (HEP) antioxidant activity and ergothioneine yield rather than nerve growth factor stimulation.

Are there human studies on Hokkaido Lion's Mane supplements?

As of current published literature, no human clinical trials have been conducted specifically on the Hokkaido cultivar of Hericium erinaceus. All available research is limited to in vitro laboratory studies examining polysaccharide extraction methods and ergothioneine quantification, meaning health benefit claims for this specific strain cannot yet be clinically substantiated.

What does HEP (Hericium erinaceus polysaccharide) do?

HEPs isolated from the Hokkaido strain have shown free radical scavenging activity in DPPH and ABTS assays in vitro, suggesting antioxidant potential at the cellular level. However, these findings come exclusively from laboratory models, and it is unknown whether orally consumed HEPs are absorbed and distributed in sufficient concentrations to replicate these effects in humans.

Can Hokkaido Lion's Mane interact with medications?

No drug interaction studies exist for the Hokkaido strain's HEP extracts specifically. Based on general mushroom polysaccharide pharmacology, there is a theoretical risk of additive effects with antiplatelet or anticoagulant drugs such as warfarin or clopidogrel, though this has not been confirmed in clinical studies. Anyone taking prescription medications should consult a healthcare provider before adding this supplement.

What is the difference between Hokkaido Lion's Mane extract and fruiting body powder?

Hokkaido Lion's Mane extract concentrates polysaccharides (HEPs) through extraction processes, potentially delivering higher levels of bioactive compounds per dose compared to whole fruiting body powder. Fruiting body powder contains the entire fungal material but may have lower bioavailability of specific compounds. The Hokkaido cultivar's polysaccharide profile may differ slightly from other regional strains, though direct comparative analysis is limited in published research.

How should I store Hokkaido Lion's Mane supplements to maintain potency?

Store Hokkaido Lion's Mane supplements in a cool, dry place away from direct sunlight and moisture, as polysaccharides and ergothioneine can degrade when exposed to heat and humidity. Airtight containers or sealed capsules help preserve bioactive compounds longer than open powder formulations. Refrigeration may extend shelf life for certain extract forms, though room temperature storage in proper packaging is typically adequate for most supplement preparations.

Why is Hokkaido specifically cultivated for Lion's Mane supplements?

The Hokkaido cultivar (Hericium erinaceus 'Hokkaido') was selected for its polysaccharide composition and bioactive compound profile, with laboratory studies suggesting enhanced levels of ergothioneine and HEP content compared to other strains. Japan's long history of mushroom cultivation refined growing conditions that favor this variant's development of potentially beneficial compounds. However, differences in practical supplement efficacy between Hokkaido and other cultivars have not been established through human clinical trials.

Hokkaido Lion's Mane (Hericium erinaceus 'Hokkaido')

Hokkaido Lion's Mane (Hericium erinaceus 'Hokkaido') is a cultivated strain notable for exceptionally high ergothioneine content (250–583 mg/100g dry weight), a sulfur-containing amino acid that may neutralize reactive oxygen species via mitochondrial accumulation. Current evidence is confined to extraction studies and in vitro assays, with no published human clinical trials specific to this strain.

Category: Mushroom/Fungi Evidence: 2/10 Tier: Emerging

Hokkaido Lion's Mane (Hericium erinaceus 'Hokkaido') — Hermetica Encyclopedia

Origin & History

Hokkaido Lion's Mane refers to Hericium erinaceus 'Hokkaido', a cultivar variant of the Lion's Mane mushroom native to temperate regions of the Northern Hemisphere, specifically cultivated in Hokkaido, Japan for enhanced bioactive profiles. The edible medicinal mushroom is processed using various extraction methods including hot water extraction (yielding 0.3-12.32% polysaccharides), dual water-ethanol extraction, and supercritical CO2 extraction to obtain compounds like polysaccharides, terpenoids (hericenones/erinacines), phenolics, and sterols.

Historical & Cultural Context

No historical or traditional medicine context is provided in the available research sources. The sources do not reference any traditional systems like TCM, historical duration of use, or traditional indications.

Health Benefits

• No human clinical trials available - research limited to extraction methods and in vitro activities
• Polysaccharide extracts (HEPs) show potential antioxidant effects in laboratory studies only
• Contains ergothioneine (250-583 mg/100g dry weight) - a compound with theoretical antioxidant properties but no human studies provided
• Laboratory analysis identifies bioactive compounds like hericenones and erinacines with no clinical evidence presented
• Traditional medicinal use suggested but no documentation provided in available research

How It Works

Ergothioneine, present at 250–583 mg/100g dry weight in this strain, is transported into human cells via the organic cation transporter OCTN1 (SLC22A4) and preferentially accumulates in mitochondria, where it may scavenge hydroxyl radicals and peroxynitrite. The strain's polysaccharide extracts (HEPs) have demonstrated free radical scavenging activity in DPPH and ABTS assays in vitro, potentially via inhibition of lipid peroxidation and modulation of superoxide dismutase-like activity. No receptor-binding or enzyme-inhibition data from human tissue are currently available for the Hokkaido cultivar specifically.

Scientific Research

The research dossier explicitly states that search results provide no human clinical trials, RCTs, or meta-analyses specifically for Hericium erinaceus 'Hokkaido' or general H. erinaceus. Available sources focus solely on extraction methods, structural analysis, and in vitro activities without referencing any PubMed PMIDs for human studies.

Clinical Summary

No human clinical trials have been conducted specifically on the Hokkaido cultivar of Hericium erinaceus. Available research consists exclusively of in vitro extraction studies characterizing polysaccharide fractions (HEPs) and ergothioneine quantification assays measuring content across drying and cultivation conditions. While broader Hericium erinaceus research includes small human trials (typically 30–80 participants) on cognitive function using hericenones and erinacines, these findings cannot be extrapolated to the Hokkaido strain's HEP fractions without strain-specific data. The current evidence base rates as preliminary at best, and any claimed health benefits remain unsubstantiated at the clinical level.

Nutritional Profile

Hokkaido Lion's Mane (Hericium erinaceus 'Hokkaido') is a cultivated variant with the following approximate compositional profile based on available analytical data for H. erinaceus dry weight: Protein: 20-35% (containing all essential amino acids; glutamic acid, aspartic acid, and leucine among dominant fractions); Carbohydrates: 40-60% (predominantly beta-glucan polysaccharides including beta-1,3 and beta-1,6 glucan linkages, estimated 15-30% of dry weight as immunologically active polysaccharides); Dietary Fiber: 15-25% dry weight (combination of soluble and insoluble fractions); Fat: 2-5% dry weight (primarily linoleic acid among fatty acids); Moisture (fresh weight): approximately 85-92%. Key Bioactive Compounds: Hericenones (C-E, hericenone derivatives; lipid-soluble, found predominantly in fruiting body, approximate concentrations 0.01-0.05% dry weight); Erinacines (A-I; diterpenoid compounds found primarily in mycelium, less abundant in fruiting body); Ergothioneine: 250-583 mg/100g dry weight (notably high compared to common culinary mushrooms; a sulfur-containing amino acid derivative synthesized via fungal-specific pathway); Hericium polysaccharides (HEPs): variable concentration 10-40% depending on extraction method. Micronutrients: Potassium (~400-500 mg/100g dry weight); Phosphorus (~800-1100 mg/100g dry weight); Zinc (~1-3 mg/100g dry weight); Copper (~0.2-0.5 mg/100g dry weight); B-vitamins including riboflavin (B2) and niacin (B3) at moderate concentrations; Vitamin D2 (ergocalciferol) present at low baseline levels, significantly increased with UV light exposure. Bioavailability Notes: Beta-glucan bioavailability is influenced by cell wall integrity; cooking or mechanical processing improves polysaccharide extractability. Ergothioneine is absorbed via specific OCTN1 transporter in humans with relatively high bioavailability (~50-60% estimated from fungal food sources). Hericenones are lipid-soluble and may benefit from co-consumption with dietary fat. The 'Hokkaido' cultivar designation suggests cold-climate cultivation conditions which may upregulate stress-response metabolites including ergothioneine and certain polysaccharide fractions, though cultivar-specific quantitative comparisons against standard H. erinaceus remain limited in peer-reviewed literature.

Preparation & Dosage

No clinically studied dosage ranges are available as the sources lack human trials. Extraction yields vary by method (polysaccharides 0.3-12.32% via hot water; ergothioneine 250-583 mg/100g via dual extraction), but no standardization or clinical dosing has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other medicinal mushrooms, adaptogenic herbs, nootropic compounds, antioxidants, immune-supporting nutrients

Safety & Interactions

The Hokkaido Lion's Mane strain has no dedicated human safety studies; general Hericium erinaceus data suggest it is well tolerated at culinary doses, with rare reports of skin rashes or respiratory symptoms in sensitive individuals. Ergothioneine, its primary bioactive, is considered safe as it is a naturally occurring dietary compound found in mushrooms and meat, with no established upper tolerable intake limit. Theoretical caution applies with anticoagulant medications (e.g., warfarin) based on broader mushroom polysaccharide data, though no interaction studies exist for HEPs specifically. Pregnant or breastfeeding individuals should avoid supplemental doses due to a complete absence of safety data in these populations.